Loading the section
The price of BriaCell Therapeutics Corp. (BCTX) on October 9, 2026 is 3.95 USD, +0.87% on the day. Over 52 weeks the stock traded between 2.60 USD and 14.68 USD; the price now sits 11% of the way up that range. Over the past year the price changed by -68.96%. Market capitalization is 1.66 million USD, rank 355 among 374 stocks of the same industry with a known capitalization.
Prices delayed by 15 minutes
Next earnings report: 21 October 2026 · Earnings calendar
BriaCell Therapeutics Corp. trades on Nasdaq under the ticker BCTX. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks BCTX has traded between 2.60 $ and 14.68 $. As of 09 October 2026 the price stood 10.93 % of the way from the 52-week low to the high.
Over one year BCTX shares fell 68.96 %; over six months they fell 13.66 %. Volatility over 90 days is 71.62 %. Dividends are not included: this is price change only, as of 09 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to book is 0.1, below the sector median of 2.4. Calculated from reports for the period ending 30 April 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 08 October 2026 | 4.05 | 4.05 | 3.87 | 3.92 | 48,700 |
| 07 October 2026 | 4.00 | 4.10 | 3.91 | 4.00 | 84,400 |
| 06 October 2026 | 4.20 | 4.23 | 3.99 | 4.02 | 69,100 |
| 05 October 2026 | 4.04 | 4.22 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 30 April 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
No events for this security recently.
Address:3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER, BC, V7T 2X1, CA
BCTX has a return on equity of −131.04 %, below the sector median of −41.68 %. Return on assets is −113.31 %, below the sector median of −32.11 %.
| 1.2B |
| PFEPfizer, Inc. | 28.18 | +1.28 % | 929M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 3.94 |
| 4.18 |
| 59,400 |
| 02 October 2026 | 4.17 | 4.33 | 4.01 | 4.04 | 104,900 |
| 01 October 2026 | 4.31 | 4.31 | 4.11 | 4.11 | 61,500 |
| 30 September 2026 | 4.08 | 4.34 | 4.01 | 4.28 | 88,000 |
| 29 September 2026 | 4.20 | 4.20 | 3.97 | 4.08 | 181,800 |
| 28 September 2026 | 4.21 | 4.40 | 4.01 | 4.16 | 293,400 |
| 25 September 2026 | 4.34 | 4.37 | 4.17 | 4.32 | 140,000 |
| 24 September 2026 | 4.08 | 4.43 | 3.99 | 4.28 | 241,700 |
| 23 September 2026 | 4.01 | 4.18 | 3.98 | 4.01 | 64,800 |
| 22 September 2026 | 4.15 | 4.37 | 3.92 | 4.09 | 188,600 |
| 21 September 2026 | 4.16 | 4.22 | 4.03 | 4.15 | 167,600 |
| 18 September 2026 | 4.17 | 4.38 | 4.03 | 4.21 | 269,900 |
| 17 September 2026 | 3.57 | 4.35 | 3.57 | 4.22 | 500,400 |
| 16 September 2026 | 3.57 | 3.62 | 3.52 | 3.56 | 66,000 |
| 15 September 2026 | 3.57 | 3.58 | 3.48 | 3.58 | 67,000 |
| 14 September 2026 | 3.58 | 3.65 | 3.56 | 3.56 | 96,200 |
| 11 September 2026 | 3.68 | 3.77 | 3.61 | 3.63 | 74,700 |